Cibc Private Wealth Group, LLC Astrazeneca PLC Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
 - Q1 2025
 
A detailed history of Cibc Private Wealth Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 8,218,863 shares of AZN stock, worth $672 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
8,218,863
              Previous 8,105,996
              
        
           1.39%
        
      
          
        Holding current value
$672 Million
            Previous $531 Million
            
        
           13.74%
        
      
          
        % of portfolio
1.18%
            Previous 1.01%
          
        Shares
	  34 transactions
	
  Others Institutions Holding AZN
# of Institutions
1,448Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M- 
    
      Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.24 Billion0.41% of portfolio
 - 
    
      Primecap Management CO Pasadena, CA41.2MShares$3.37 Billion2.35% of portfolio
 - 
    
      Wellington Management Group LLP Boston, MA34.3MShares$2.81 Billion0.45% of portfolio
 - 
    
      Capital International Investors Los Angeles, CA31.4MShares$2.57 Billion0.39% of portfolio
 - 
    
      Bank Of America Corp Charlotte, NC31.2MShares$2.55 Billion0.16% of portfolio
 
About ASTRAZENECA PLC
- Ticker AZN
 - Exchange OTC
 - Sector Healthcare
 - Industry Drug Manufacturers—General
 - Shares Outstandng 3,099,020,032
 - Market Cap $253B
 - Description
 - AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...